DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Priority
Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claim(s) 1-11 is/are rejected under 35 U.S.C. 102(a)(1)/102(a)(2) as being anticipated by Ger et al. (U.S. Publication Number 2021/0102151).
Referring to claim 1, Ger et al. discloses comprising an organ chip and a magnetic field
generating module, the organ chip comprising a first body, a second body, and a magnetically-driven porous membrane (paragraphs 0029 & 0042), wherein: the magnetically-driven porous membrane is disposed between the first body and the second body and forms a channel system with the first body and the second body, the magnetically-driven porous membrane comprises a magnetic material and a membrane body, and the magnetic material is disposed in the membrane body (paragraphs 0029 & 0042) and the magnetic field generating module is disposed outside the organ chip and is adapted to generate a magnetic field, the magnetic field passes through the magnetically-driven porous membrane and causes the magnetically-driven porous membrane to stretch, deform, or a combination thereof in response to a magnetic force in the magnetic field (paragraphs 0029 & 0042).
Referring to claim 2, Ger et al. discloses further comprising a power supply, wherein the power supply is electrically connected to the magnetic field generating module and is adapted to supply power to the magnetic field generating module (Figs. 3 & 4).
Referring to claim 3, Ger et al. discloses wherein the magnetic field generating module comprises an electromagnet, the power supply further supplies an electric current, and the electric current is adapted to cause the electromagnet to have a magnetic effect and generate a magnetic field.
Referring to claim 4, Ger et al. discloses wherein the electromagnet is adapted to generate a magnetic force of 0 Kg to 30 Kg and a voltage of 12 V to 110 V (Figure 8)
Referring to claim 5, Ger et al. discloses wherein the magnetic material comprises a plurality of particles of iron, cobalt, nickel, or alloys or compounds thereof, the membrane body is made of a hydrophilic polymer material, and the plurality of particles of the magnetic material is distributed in the membrane body (Fig. 8).
Referring to claim 6, Ger et al. discloses wherein the magnetic material is a carbonyl magnetic iron powder, the membrane body is made from hydrogel, and a weight ratio of the carbonyl magnetic iron powder to the hydrogel is 0.5:1 to 4:1 (paragraph 0029 & 0042).
Referring to claim 7, Ger et al. discloses wherein the magnetic force in the magnetic field is adapted to attract the magnetic material to drive the magnetically-driven porous membrane to stretch, deform, or a combination thereof (paragraph 0029 & 0042).
Referring to claim 8, Ger et al. discloses wherein the magnetic force in the magnetic field is adapted to repel the magnetic material to drive the magnetically-driven porous membrane to stretch, deform, or a combination thereof (Figure 8).
Referring to claim 9, Ger et al. discloses wherein the magnetic field generating module is further disposed on the first body or the second body of the organ chip (paragraphs 0029 & 0042).
Referring to claim 10, Ger et al. discloses wherein the channel system comprises a first channel and a second channel, the first channel is located between the first body and the magnetically-driven porous membrane, the second channel is located between the second body and the magnetically-driven porous membrane, and a stretching of the magnetically-driven porous membrane comprises stretching toward the first channel or toward the second channel (paragraphs 0029 & 0042).
Referring to claim 11, Ger et al. discloses wherein the stretching of the magnetically-driven porous membrane toward the first channel compresses the first channel, and the stretching toward the second channel compresses the second channel (Fig. 2 & 3).
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KESHA FRISBY whose telephone number is (571)272-8774. The examiner can normally be reached Monday-Friday 730AM-4PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Xuan Thai can be reached at 571-272-7147. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/KESHA FRISBY/Primary Examiner, Art Unit 3715
Prosecution Insights